Biomodulation of 5-fluorouracil by interferon-α in human renal carcinoma cells: Relationship to the expression of thymidine phosphorylase

Cancer Chemotherapy and Pharmacology

Volumn 44, Issue 2, 1999, Pages 91-96

  Morita, Tatsuo ^a   Tokue, Akihiko ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

5 Fluorouracil; Biomodulation; Interferon; Renal cell carcinoma; Thymidine phosphorylase

Indexed keywords

FLUOROURACIL; RECOMBINANT ALPHA2A INTERFERON; THYMIDINE PHOSPHORYLASE;

ARTICLE; CARCINOMA CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MODULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, RENAL CELL; FLUOROURACIL; HUMANS; INTERFERON-ALPHA; KIDNEY NEOPLASMS; THYMIDINE PHOSPHORYLASE; TUMOR CELLS, CULTURED;

EID: 0033030892     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050951     Document Type: Article

References (37)

1. 3-thymidine incorporation assay. J Immunol Methods 170: 211
2. 2. Atzpodien J, Kirchner H, Hanninen EL, Deckert M, Fenner M, Poliwoda H (1993) Interleukin-2 in combination with interferon-α and 5-fluorouracil for metastatic renal cell carcinoma. Eur J Cancer 29: S6
3. 3. Belldegrun A, Abi-Aad AS, Figlin RA, DeKernion JB (1991) Renal cell carcinoma: basic biology and current approaches to therapy. Semin Urol 18: 96
4. 4. DeKernion JB, Ramming KP, Smith RB (1978) The natural history of metastatic renal cell carcinoma: a computer analysis. J Urol 120: 148
5. 5. Eda H, Fujimoto K,Watanabe S, Ura M, Hino A, Tanaka Y, Wada K, Ishitsuka H (1993) Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine. Cancer Chemother Pharmacol 32: 333
6. 6. Eda H, Fujimoto K, Watanabe S, Ishikawa T, Ohiwa T, Tatsuno K, Tanaka Y, Ishitsuka H (1993) Cytokines induce uridine phosphorylase in mouse colon 26 carcinoma cells and make the cells more susceptible to 5′-deoxy-5-fluorouridine. Jpn J Cancer Res 84: 341
7. 7. Elias L, Crissman HA (1988) Inerferon effects upon the adenocarcinoma 38 and HL-60 cell lines: antiproliferative responses and synergistic interactions with halogenated pyrimidine antimetabolites. Cancer Res 48: 4868
8. 8. Elias L, Blumenstein BA, Kish J, Flanigan RC, Wade JL, Lowe BA, Goodwin JW, Crawford ED (1996) A phase II trial of interferon-α and 5-fluorouracil in patients with advanced renal cell carcinoma. A Southwest Oncology Group Study. Cancer 78: 1085
9. 9. Furukawa T, Yoshimura A, Sumizawa T, Haraguchi M, Akiyama S, Fukui K, Ishizawa M, Yamada Y (1992) Angiogenic factor. Nature 356: 66
10. 10. Gebrosky NP, Koukol S, Nseyo UO, Carpenter C, Lamm DL (1997) Treatment of renal cell carcinoma with 5-fluorouracil and alpha-interferon. Urology 50: 863
11. 11. Haarstad H, Jacobsen AB, Schjlseth SA, Risberg T, Fossa SD (1994) Interferon-alpha, 5-FU and prednisone in metastatic renal cell carcinoma: a phase II study. Ann Oncol 5: 245
12. 12. Hrouda D, Muir GH, Dalgleish AG (1997) The role of immunotherapy for urological tumours. Br J Urol 79: 307
13. 13. Imazono Y, Takebayashi Y, Nishiyama K, Akiba S, Miyadera K, Yamada Y, Akiyama S, Ohi Y (1997) Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma. J Clin Oncol 15: 2570
14. 14. Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, Usuki K, Takai F, Risau WW, Heldin CH (1989) Identification of angiogenic activity and the cloning and the expression of platelet-derived endothelial cell growth factor. Nature 338: 557
15. 15. Ishikawa T, Sekiguchi F, Fukase Y, Sawada N, Ishitsuka H (1998) Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts. Cancer Res 58: 685
16. 16. Koukourakis MI, Giatromanolaki A, O'byrne KJ, Comley M, Whitehouse RM, Talbot DC, Gatter KC, Harris AL (1997) Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer. Br J Cancer 75: 477
17. 17. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, Sawada T, Onoda N, Kato Y, Sowa M (1996) Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer 73: 884
18. 18. Muraki J, Sugaya Y, Kobayashi M, Hashimoto S, Morita T, Kobayashi Y, Tokue A, Nakazono M (1997) Establishment of two renal cancer cell lines. Acta Urol Jpn 43: 177
19. 19. Nishida M, Hino A, Mori K, Matsumoto T, Yoshikubo T, Ishitsuka H (1996) Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues. Biol Pharm Bull 19: 1407
20. 20. O'Brien TS, Fox SB, Dickinson AJ, Turley H, Westwood M, Moghaddam A, Gatter KC, Bicknell R, Harris AL (1996) Expression of the angiogenic factor thymidine phosphorylase/ platelet-derived endothelial cell growth factor in primary bladder cancers. Cancer Res 56: 4799
21. 21. Reynolds K, Farzaneh F, Collins WP, Campbell S, Bourne TH, Lawton F, Moghaddam A, Harris AL, Bickell R (1994) Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J Natl Cancer Inst 86: 1234
22. 22. Sawada N, Ishikawa T, Fukase Y, Nishida M, Yoshikubo T, Ishitsuka H (1998) Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts. Clin Cancer Res 4: 1013
23. 23. Schwartz EL, Hoffman M, O'Connor CJ, Wadler S (1992) Stimulation of 5-fluorouracil metabolic activation by interferon-α in human colon carcinoma cells. Bioch Biophys Res Commun 182: 1232
24. 24. Schwartz EL, Baptiste N, Megati S, Wadler S, Otter BA (1995a) 5-Ethoxy-2′-deoxyuridine, a novel substrate for thymidine phosphorylase, potentiates the antitumor activity of 5-fluorouracil when used in combination with interferon, an inducer of thymidine phosphorylase expression. Cancer Res 55: 3543
25. 25. Schwartz EL, Baptiste N, Wadler S, Makower D (1995) Thymidine phosphorylase mediates the sensitivity of human colon carcinoma cells to 5-fluorouracil. J Biol Chem 270: 19073
26. 26. Sella A, Logothetics CJ, Fitz K, Dexeus FH, Amato R, Kilbourn R, Wallace S (1992) Phase II study of interferon-α and chemotherapy (5-fluorouracil and mitomycin C) in metastatic renal cell cancer. J Urol 147: 573
27. 27. Sotos GA, Grogan L, Allegra CJ (1994) Preclinical and clinical aspects of biomodulation of 5-fluorouracil. Cancer Treat Rev 20: 11
28. 28. Swanson DA (1993) Is cytotoxic chemotherapy effective in the treatment of advanced renal cell carcinoma? Semin Urol 11: 35
29. 29. Takebayashi Y, Yamada K, Miyadera K, Sumizawa T, Furukawa T, Kinoshita F, Aoki D, Okumura H, Yamada Y, Akiyama S, Aikou T (1996) The activity and expression of thymidine phosphorylase in human solid tumours. Eur J Cancer 32A: 1227
30. 30. Takebayashi Y, Akiyama S, Akiba S, Yamada K, Miyadera K, Sumizawa T, Yamada Y, Murata F, Aikou T (1996b) Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 88: 1110
31. 31. Tevaearai HT, Laurent PL, Suardet LL, Eliason JF, Givel JC, Odartchenko N (1992) Interactions of interferon-α 2a with 5′-deoxy-5-fluorouridine in colorectal cancer cells in vitro. Eur J Cancer 28: 368
32. 32. Toi M, Hoshina S, Taniguchi T, Yamamoto Y, Ishitsuka H, Tominaga T (1995) Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in human breast cancer. Int J Cancer 64: 79
33. 33. Wadler S, Schwartz EL (1990) Antineoplastic activity of the combination of Interferon and cytotoxic agents against experimental and human malignancies: a review. Cancer Res 50: 3473
34. 34. Wadler S, Schwartz EL, Goldman M, Lyver A, Rader M, Zimmerman M (1989) Fluorouracil and recombinant alpha-2a-interferon: an active regimen against advanced colorectal carcinoma. J Clin Oncol 7: 1769
35. 35. Wadler S, Wersto R, Weinberg V, Thompson D, Schwartz EL (1990) Interaction of fluorouracil and Interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects. Cancer Res 50: 5735
36. 36. Wadler S, Horowitz R, Mao X, Schwartz EL (1996) Effect of Interferon on 5-fluorouracil-induced perturbations in pools of deoxynucleotide triphosphates and DNA strand breaks. Cancer Chemother Pharmacol 38: 529
37. 37. Yoshimura A, Kuwazuru Y, Furukawa T, Yoshida H, Yamada K, Akiyama S (1990) Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors. Bioch Biophys Acta 1034: 107